AzTrials
AzTrials

Fluid OverloadDialysisSuitNCT07030361

Intradıalytıc Weıght Control In Hemodıalysıs Patıents

A study testing suit group and training group in people with Fluid Overload, run by Balikesir University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this observational study is to determine the effect of a dialysis gown designed according to the empowerment model on changes in weight control behaviors among gown group patients during the intradialytic period. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Fluid Overload
What is being tested?
suit group and training group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
66 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Feb 2023to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Turkish-speaking
  • Turkish-understanding
  • Older than 18 years of age
  • Without communication barriers such as visual and hearing impairment
  • Non-hypotensive and non-anemic patients
  • With an intradialytic weight of 2-5 liters
  • Receiving hemodialysis treatment for more than three months and outpatients

Who cannot join

  • Patients who had previously received fluid restriction compliance training
  • Who refused to participate in the study
  • Who had undergone surgery within the last six weeks

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Balikesir University

    Balıkesir, 10145

Other trials in Turkey (Türkiye)

About this study

Official title: Innovative Dialaysis Suit for Hemodialysis Patients Effect of Fluid Restriction on Compliance and Level of Empowerment: Randomise Controlled Trials

The aim of this observational study is to determine the effect of a dialysis gown designed according to the empowerment model on changes in weight control behaviors among gown group patients during the intradialytic period. The main question it seeks to answer is:

  • Is the dialysis gown effective in helping gown group patients control their fluid intake during the intradialytic period?
Read the detailed description

In this study, researchers designed a study to compare whether the behavior of controlling excessive fluid intake during the intradialytic period was better in the group of patients wearing dialysis garments designed according to the empowerment model than in the education and control groups. For this randomized controlled study, patients were divided into three groups. The patients were named the garment group, the education group, and the control group. In the study design, patients underwent garment application and education application. In the garment application, the amount of excess fluid removed by ultrafiltration during that dialysis session was placed in the pockets of the serum dialysis garment, and patients were asked to walk in a 10-meter walking test area. In the education application, a video-based education program designed to teach fluid compliance behavior was implemented. Patients were asked to watch this video education program for an average of half an hour at the beginning of each session.

Patients in the garment group were dressed in dialysis garments and shown the educational video. Patients in the education group were only shown the fluid compliance video. No intervention specific to the study was performed on patients in the control group. All patients continued to receive the normal follow-up and care protocol required for hemodialysis treatment.

Conditions
Fluid Overload
Being tested
suit group, training group, control group
Keywords
FluidControl, Compliance, Empowerment, İnnovation, DialysisSuit;
Medical subject headings
Edema, Patient Compliance, Empowerment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • suit groupBehavioural

    elbise giydirme ve video izletme uygulaması

  • training groupBehavioural

    video izletme uygulaması

  • control groupBehavioural

    rutin hemş bakımı uygulaması, herhangi bir müdahale yok

Study groups in NCT07030361
Study groupRoleWhat they receive
suits groupActive comparatorDialysis suit group was dressed in dialysis suit and given fluid control training
Receives: Behavioral: suit group
2 training groupPlacebo comparatorFluid control training was given to the traininig group
Receives: Behavioral: training group
control groupOtherControl group received no intervention, clinical care
Receives: Behavioral: control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intradialytic fluid balance

    weight gained during the intradialytic period

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2025
  2. Study start22 Feb 2023
  3. Primary completion5 Jul 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Research data were collected in 3 stages: pretest (Z0), posttest (Z1) and follow-up test (Z2).
Masking
Single blind
Who is masked
Participant
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07030361
Sponsor's protocol ID
BalikesirUniversity HealtScien
Other IDs
222S306
Acronym
DialysisSuit
Status last verified
Jun 2025
First submitted
17 Apr 2025
Last updated
22 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: the product used in the research has not yet entered the production phaset

Questions about this trial

What is this clinical trial studying?

A study testing suit group and training group in people with Fluid Overload, run by Balikesir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intradialytic fluid balance (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in